Fluicell AB (publ) (FLUI.ST)

SEK 0.04

(0.5%)

Market Cap (In SEK)

19.32 Million

Revenue (In SEK)

3.33 Million

Net Income (In SEK)

-26.55 Million

Avg. Volume

4.43 Million

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.038-0.951
PE
-
EPS
-
Beta Value
1.773
ISIN
SE0010831321
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Victoire Viannay
Employee Count
-
Website
https://www.fluicell.com
Ipo Date
2018-04-18
Details
Fluicell AB (publ) provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company offers BioPen PRIME and BioPen FLEX microfluidic systems for maintaining localized solution delivery in single-cell experiments, as well as enabling control of the chemical environment around single intact cells in tissue or cell cultures; and Dynaflow Resolve system, a secondary ion channel screening platform, which allows for recording of various ion channel current in patch-clamp recording configuration. The company was founded in 2012 and is based in Gothenburg, Sweden.